Celiac disease develops when three things converge in the same person: a specific genetic makeup, exposure to gluten, and an immune system that reacts to gluten as though it were a threat. Remove any one of those three and the disease does not appear. Nearly all people with celiac disease carry genes for immune molecules called HLA-DQ2 or HLA-DQ8, yet most people who carry those genes never develop the condition, which means something else has to tip the balance. That “something else” is where the science gets interesting and, honestly, still incomplete.
The Genetic Foundation
The single biggest risk factor is inherited. Two gene variants that code for specific immune-system proteins, HLA-DQ2 and HLA-DQ8, are carried by almost every person diagnosed with celiac disease.1PubMed Central. Genetic susceptibilty and celiac disease: what role do HLA haplotypes play? A meta-analysis found that people with celiac disease are roughly two and a half times more likely to express HLA-DQ2 than unaffected controls.2PubMed Central. Meta-Analysis and Systematic Review of HLA DQ2/DQ8 in Adults with Celiac Disease These proteins sit on immune cells and present fragments of digested food to the rest of the immune system. When that fragment happens to be a piece of gluten, HLA-DQ2 and HLA-DQ8 hold onto it especially well, which can set off a chain reaction.
But genetics is not destiny. About 30 to 40 percent of the general population in many Western countries carries HLA-DQ2 or DQ8, yet only a small fraction of them develop celiac disease. That gap tells researchers that these genes are necessary but not sufficient. Twin studies make the point clearly: identical twins, who share the same DNA, show a concordance rate of about 83 percent, while fraternal twins show only about 17 percent.3BMJ Journals. Concordance, disease progression, and heritability of coeliac disease in Italian twins The fact that identical twins are not 100 percent concordant proves that non-genetic factors play a role, even if genetics accounts for the majority of risk.
Beyond HLA, researchers have identified dozens of additional gene regions that contribute smaller amounts of risk. A large pediatric study found variants in genes involved in immune signaling and gut inflammation, and a population screening study recently identified 15 new genome-wide significant variants in 11 previously unknown locations.4PubMed Central. Identification of Non-HLA Genes Associated with Celiac Disease and Country-Specific Differences in a Large, International Pediatric Cohort 5Scientific Reports. Population screening of adults identifies novel genetic variants associated with celiac disease Each individual variant adds a small amount of susceptibility, and many are shared with other autoimmune conditions, which helps explain why celiac disease tends to cluster in families alongside type 1 diabetes and thyroid disorders.
What Gluten Does Inside the Gut
Gluten is a family of storage proteins found in wheat, barley, and rye. What makes it unusual is its amino acid makeup: it is packed with proline and glutamine, two building blocks that make it stubbornly resistant to the digestive enzymes in your stomach and small intestine.6Trends in Food Science & Technology. Possibility of minimizing gluten intolerance by co-consumption of some fruits – A case for positive food synergy? Most dietary proteins get chopped into tiny, harmless pieces. Gluten leaves behind larger fragments, called peptides, that your body has trouble breaking down further.7PubMed Central. Effective Degradation of Gluten and Its Fragments by Gluten-Specific Peptidases: A Review on Application for the Treatment of Patients with Gluten Sensitivity
In someone with celiac disease, those surviving gluten fragments slip through the gut lining and encounter an enzyme called tissue transglutaminase (often abbreviated TG2). This enzyme chemically modifies the gluten peptides by converting certain glutamine residues into glutamic acid, a process called deamidation. The proline-rich structure of gluten actually makes it an especially good target for TG2.8PubMed. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease The modified peptides now carry a negative charge, which lets them lock tightly into the groove of those HLA-DQ2 or DQ8 molecules on immune cells. That binding event is the spark.
Once the modified gluten fragments are displayed by HLA-DQ2 or DQ8, a specific population of immune cells recognizes them and launches an inflammatory attack. Inflammatory signaling molecules flood the area, and another group of immune cells begins killing the cells lining the small intestine. Over time, this destroys the finger-like projections (villi) that absorb nutrients, leading to the flattening and damage visible on a biopsy.9PubMed Central. Pathogenesis of coeliac disease: implications for treatment TG2 is also the target of the autoantibodies that show up on celiac blood tests, which is why the same enzyme sits at the center of both the disease mechanism and the diagnostic workup.10PubMed Central. T Cells in Celiac Disease
The Role of Gut Permeability
For the immune reaction to happen, those gluten fragments have to cross the gut lining and reach the immune cells underneath. In a healthy gut, the cells lining the intestine are sealed together tightly. Research has pointed to a protein called zonulin, which regulates the gaps between intestinal cells. Children who later went on to develop celiac disease showed a significant rise in zonulin levels in the months before diagnosis, suggesting that increased gut permeability may be an early step in the disease process rather than just a consequence of it.11PubMed Central. Zonulin as a Biomarker for the Development of Celiac Disease Whether rising zonulin is a cause or an early marker of the immune activation already underway is still debated, but it does appear to precede the full-blown disease.
Viral Infections as a Trigger
One of the more surprising findings in celiac research is that a seemingly harmless viral infection can break the immune system’s tolerance to gluten. A landmark study showed that reovirus, a common intestinal virus that typically causes no symptoms, was able to disrupt the normal immune response to dietary proteins in mice. Instead of teaching the immune system to ignore food, infection redirected it toward an inflammatory response. Importantly, the researchers also found evidence in humans that prior reovirus infection was linked to celiac disease development.12PubMed Central. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease
Enteroviruses are another suspect. A recent study demonstrated that a specific enterovirus strain triggered a strong antiviral response in intestinal cells and, critically, ramped up production and activity of TG2, the same enzyme that modifies gluten into its immune-activating form.13PubMed Central. Enterovirus-driven interferon signaling induces epithelial TG2 via JAK-STAT: Implications for the onset of celiac disease That finding connects two puzzle pieces: a viral infection could simultaneously weaken the gut’s tolerance to food and amplify the enzyme that makes gluten fragments dangerous. Research has also raised the question of whether SARS-CoV-2 infection could act as a trigger for celiac autoimmunity in predisposed individuals, though the evidence is preliminary and inconclusive so far.14PubMed. Risk of celiac disease, type 1 diabetes, and thyroid disease autoimmunity during the SARS-CoV-2 pandemic in South of Sweden: insights from the TRIAD study
When You First Eat Gluten Matters Less Than You Might Think
For years, parents were told that the timing of their baby’s first exposure to gluten could prevent celiac disease. A well-designed trial tested this by giving small amounts of gluten or a placebo to infants at high genetic risk starting at four months of age, then tracked who developed celiac disease by age three. The rates were essentially the same in both groups: about 6 percent in the gluten group and about 5 percent in the placebo group.15PubMed. Randomized feeding intervention in infants at high risk for celiac disease In other words, introducing gluten early did not protect against the disease.
A systematic review and meta-analysis found something slightly different on the other end: delaying gluten introduction past six months was associated with a roughly 25 percent increase in celiac disease risk compared to introducing it between four and six months.16PubMed. Gluten Introduction to Infant Feeding and Risk of Celiac Disease: Systematic Review and Meta-Analysis So introducing gluten very late may modestly raise risk, but pushing it early does not appear to help. The overall picture is that the timing of gluten introduction has a much smaller effect than genetics and immune triggers do. A separate UK study suggested some benefit to introducing gluten at around four months, but the evidence remains mixed across populations.17PubMed Central. Can early introduction of gluten reduce risk of celiac disease?
Gut Bacteria and the Developing Immune System
The community of microbes living in your intestines appears to influence whether celiac disease takes hold, though the evidence here is still in its early stages. A longitudinal study following children at genetic risk found that those who eventually developed celiac disease had detectable shifts in their gut microbiome well before diagnosis. Certain bacterial species associated with inflammation were more abundant, while species known for anti-inflammatory effects were less abundant, in children who went on to develop the disease.18PubMed Central. Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study
Similar patterns showed up in another study tracking gut bacteria trajectories in infants. The findings suggested that alterations in the early development of the gut microbiome in at-risk infants could influence immune maturation and predispose to celiac disease, though the authors noted that larger studies are needed to confirm this.19PubMed Central. Gut microbiota trajectory in early life may predict development of celiac disease The question of whether certain bacterial patterns cause or merely accompany the early stages of celiac disease remains unresolved.20PubMed Central. Celiac Disease and the Microbiome It is plausible that factors like antibiotic use, mode of delivery at birth, and early diet all shape the microbiome in ways that either protect against or enable celiac disease, but none of these have been definitively proven as independent risk factors.
Why Celiac Disease Can Appear at Any Age
Many people assume celiac disease is a childhood condition. It is not. The average age of diagnosis in adulthood falls between 46 and 56, and about a quarter of cases are diagnosed in people over 60. Someone can eat gluten for decades without apparent problems and then develop the disease seemingly out of nowhere. What changes? The genetics were always there, and gluten was always being consumed, so the missing piece is likely a triggering event that shifts the immune system from tolerance to attack. Stressful life events, pregnancy, surgery, and viral infections are all commonly reported before adult-onset celiac disease, though proving a direct causal link in any individual case is difficult.
The Connection to Other Autoimmune Diseases
Celiac disease does not exist in isolation. Between 10 and 30 percent of people with celiac disease test positive for antibodies against the thyroid gland or the insulin-producing cells of the pancreas. Conversely, roughly 5 to 7 percent of people with autoimmune thyroid disease or type 1 diabetes test positive for celiac antibodies.21PubMed. Celiac disease and endocrine autoimmunity – the genetic link The overlap is largely explained by shared genetic susceptibility: the same HLA variants that predispose to celiac disease also predispose to these other conditions, along with additional immune-regulation genes that raise the odds of multiple autoimmune diseases developing in the same person.
This has a practical implication. If you have been diagnosed with one autoimmune condition, especially type 1 diabetes or Hashimoto’s thyroiditis, screening for celiac disease is worth discussing with your doctor even if you have no digestive symptoms. Celiac disease can be silent for years, causing nutrient malabsorption and bone loss without obvious gut complaints.
Why Cases Are Rising
Celiac disease is not just being diagnosed more often because of better testing. A systematic review found that the true incidence has been increasing by about 7.5 percent per year over the past several decades across the Western world.22PubMed. Incidence of Celiac Disease Is Increasing Over Time: A Systematic Review and Meta-analysis Genetics does not change that fast in a population, so something environmental must be driving the increase. Candidate explanations include changes in wheat cultivars and how grain is processed, rising rates of childhood antibiotic use altering the gut microbiome, changes in infant feeding practices, and increased overall hygiene reducing early microbial exposure. None of these has been pinned down conclusively. Interestingly, the geographic spread of celiac-predisposing genes may itself reflect an ancient evolutionary pattern: one study found that populations with the longest histories of wheat consumption also had the highest frequencies of HLA-DQ2, likely the result of the farming populations of the Middle East spreading into Europe thousands of years ago.23PubMed. Co-localization of gluten consumption and HLA-DQ2 and -DQ8 genotypes, a clue to the history of celiac disease
Celiac Disease Versus Other Reactions to Gluten
Celiac disease is not the only way the body can react badly to gluten. Wheat allergy is a distinct immune response involving different antibodies (IgE) and can cause rapid symptoms like hives, swelling, or anaphylaxis. Non-celiac gluten sensitivity causes digestive and other symptoms after eating gluten but does not produce the intestinal damage or specific antibodies found in celiac disease.24PubMed Central. Diagnosis of gluten related disorders: Celiac disease, wheat allergy and non-celiac gluten sensitivity The clinical symptoms can look similar across all three, which is why diagnosis requires specific blood tests and, in the case of celiac disease, usually a biopsy. Going gluten-free before testing can make celiac disease harder to diagnose because the immune markers and intestinal damage may partially heal, masking the disease on tests.
When a Gluten-Free Diet Is Not Enough
For most people with celiac disease, removing gluten from the diet allows the intestine to heal and symptoms to resolve. But up to 30 percent of patients continue to experience symptoms or have ongoing intestinal inflammation despite following a strict gluten-free diet.25PubMed Central. Non-Responsive Coeliac Disease: A Comprehensive Review from the NHS England National Centre for Refractory Coeliac Disease The most common reason is unintentional gluten exposure, since gluten hides in sauces, processed foods, medications, and cross-contaminated kitchen surfaces. When truly strict adherence has been confirmed and symptoms persist, the condition is called refractory celiac disease, and it requires specialized care.
This clinical reality has driven interest in treatments that go beyond diet. Researchers are exploring enzyme supplements that could break down the stubborn gluten peptides before they trigger an immune response, as well as drugs designed to block the interaction between modified gluten fragments, HLA molecules, and the immune cells that drive the inflammatory cascade.26PubMed Central. Celiac disease: mechanisms and emerging therapeutics None of these therapies has replaced the gluten-free diet yet, but several are in clinical trials. The hope is that understanding exactly how the disease works at a molecular level will eventually yield treatments that protect the gut even when some gluten slips through.